Pegfilgrastim in primary prophylaxis of febrile neutropenia during chemotherapy of relapsed and refractory multiple myeloma: a real-life experience

被引：12
作者：
Cerchione, Claudio [1 ]
Catalano, Lucio [1 ]
Pareto, Anna Emanuele [1 ]
Picardi, Marco [1 ]
Pane, Fabrizio [1 ]
机构：
[1] Hematol AOU Federico II, Naples, Italy
来源：
SUPPORTIVE CARE IN CANCER | 2015年 / 23卷 / 02期
关键词：
Bortezomib; Febrile Neutropenia; Lenalidomide; National Comprehensive Cancer Network; National Comprehensive Cancer Network;
D O I：
10.1007/s00520-014-2490-y
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：301 / +
页数：2
相关论文
共 50 条
  • [31] Clinical Outcomes and Cost-effectiveness of Primary Prophylaxis of Febrile Neutropenia During Adjuvant Docetaxel and Cyclophosphamide Chemotherapy for Breast Cancer
    Yu, Joanne L.
    Chan, Kelvin
    Kurin, Michael
    Pasetka, Mark
    Kiss, Alex
    Sridhar, Srikala S.
    Warner, Ellen
    [J]. BREAST JOURNAL, 2015, 21 (06) : 658 - 664
  • [32] Secondary primary malignancies during the lenalidomide-dexamethasone regimen in relapsed/refractory multiple myeloma patients
    Kotchetkov, Rouslan
    Masih-Khan, Esther
    Chu, Chia-Min
    Atenafu, Eshetu G.
    Chen, Christine
    Kukreti, Vishal
    Trudel, Suzanne
    Tiedemann, Rodger
    Reece, Donna E.
    [J]. CANCER MEDICINE, 2017, 6 (01): : 3 - 11
  • [33] Brazilian Real-Life Experience of Multiple Myeloma (MMyBRAve): Improvement in Outcomes, But Remaining Diagnostic and Therapeutic Gaps
    Hungria, Vania
    Bittencourt, Rosane Isabel
    Martinez, Gracia Aparecida
    Santos, Juliana de Andrade
    de Almeida, Denise Ramos
    Figueiredo, Vera Lucia de Piratininga
    de Farias, Danielle Leao Cordeiro
    Zanella, Karla Richter
    Muniz, Larissa Barchi
    Senra, Juliana Tosta
    Abreu, Rodrigo Martins
    Mattos, Ederson Roberto
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2025, 25 (01) : 26 - 31
  • [34] Impact of second autologous stem-cell transplantation at relapsed multiple myeloma: A French multicentric real-life study
    Andre, Axel
    Montes, Lydia
    Roos-Weil, Damien
    Frenzel, Laurent
    Vignon, Marguerite
    Chalopin, Thomas
    Debureaux, Pierre-Edouard
    Talbot, Alexis
    Farge, Agathe
    Jardin, Fabrice
    Belhadj, Karim
    Royer, Bruno
    Marolleau, Jean-Pierre
    Arnulf, Bertrand
    Morel, Pierre
    Harel, Stephanie
    [J]. HEMASPHERE, 2024, 8 (08):
  • [35] Real-world outcome and healthcare costs of relapsed or refractory multiple myeloma: A retrospective analysis from the Chinese experience
    Zhou, Xin
    Xia, Jun
    Mao, Jingjue
    Cheng, Feng
    Qian, Xifeng
    Guo, Hongfeng
    [J]. HEMATOLOGY, 2016, 21 (05) : 280 - 286
  • [36] Risk Factors of Infection in Relapsed/Refractory Multiple Myeloma Patients Treated with Lenalidomide and Dexamethasone (Rd) Regimen: Real-Life Results of a Large Single-Center Study
    Mikulski, Damian
    Robak, Pawel
    Ryzewska, Wiktoria
    Stanczak, Kamila
    Koscielny, Kacper
    Gora-Tybor, Joanna
    Robak, Tadeusz
    [J]. JOURNAL OF CLINICAL MEDICINE, 2022, 11 (19)
  • [37] Efficacy and safety of lenalidomide in relapse/refractory multiple myeloma—Real life experience of a tertiary cancer center
    Cristina João
    Inês Coelho
    Carlos Costa
    Susana Esteves
    Paulo Lucio
    [J]. Annals of Hematology, 2015, 94 : 97 - 105
  • [38] Efficacy and safety of lenalidomide in relapse/refractory multiple myeloma-Real life experience of a tertiary cancer center
    Joao, Cristina
    Coelho, Ines
    Costa, Carlos
    Esteves, Susana
    Lucio, Paulo
    [J]. ANNALS OF HEMATOLOGY, 2015, 94 (01) : 97 - 105
  • [39] Outcomes of primary and secondary prophylaxis of chemotherapy-induced and febrile neutropenia in bendamustine plus rituximab regimens in patients with lymphoma and chronic lymphocytic leukemia: real-world, single-center experience
    Logan Moore
    Trace Bartels
    Daniel O. Persky
    Ivo Abraham
    Abhijeet Kumar
    Ali McBride
    [J]. Supportive Care in Cancer, 2021, 29 : 4867 - 4874
  • [40] Outcomes of primary and secondary prophylaxis of chemotherapy-induced and febrile neutropenia in bendamustine plus rituximab regimens in patients with lymphoma and chronic lymphocytic leukemia: real-world, single-center experience
    Moore, Logan
    Bartels, Trace
    Persky, Daniel O.
    Abraham, Ivo
    Kumar, Abhijeet
    McBride, Ali
    [J]. SUPPORTIVE CARE IN CANCER, 2021, 29 (08) : 4867 - 4874
12345